Affordable Access

deepdyve-link
Publisher Website

Multicenter Evaluation of the Bruker MALDI Biotyper CA System for the Identification of Clinically Important Bacteria and Yeasts.

Authors
  • Wilson, Deborah A1
  • Young, Stephen2, 3
  • Timm, Karen2
  • Novak-Weekley, Susan4
  • Marlowe, Elizabeth M4
  • Madisen, Neil5
  • Lillie, Jennifer L6
  • Ledeboer, Nathan A5, 7
  • Smith, Rebecca2
  • Hyke, Josh5
  • Griego-Fullbright, Christen2
  • Jim, Patricia2
  • Granato, Paul A6, 8
  • Faron, Matthew L7
  • Cumpio, Joven4
  • Buchan, Blake W5, 7
  • Procop, Gary W1
  • 1 From Cleveland Clinic, Cleveland, OH.
  • 2 Tricore Reference Laboratories, Albuquerque, NM.
  • 3 Department of Pathology, The University of New Mexico Health Sciences Center, Albuquerque. , (Mexico)
  • 4 Kaiser Permanente Southern California Permanente Medical Group Regional Reference Laboratories, North Hollywood, CA.
  • 5 Wisconsin Diagnostic Laboratory, Milwaukee.
  • 6 Laboratory Alliance of Central New York, Fayetteville.
  • 7 Medical College of Wisconsin, Milwaukee.
  • 8 SUNY Upstate Medical University, Syracuse, NY.
Type
Published Article
Journal
American Journal of Clinical Pathology
Publisher
Oxford University Press
Publication Date
Jun 01, 2017
Volume
147
Issue
6
Pages
623–631
Identifiers
DOI: 10.1093/ajcp/aqw225
PMID: 28505220
Source
Medline
Keywords
License
Unknown

Abstract

The Bruker MALDI Biotyper CA System accurately identifies most clinically important bacteria and yeasts and has optional processing methods to improve isolate characterization.

Report this publication

Statistics

Seen <100 times